Mupirocin: Clinical Trials

53 trials of Mupirocin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 6 unknown, 4 terminated, 2 recruiting. 17 Not applicable, 14 Phase 4, 8 Phase 2, 8 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 14, Unknown 2, Terminated 1
Phase 414Completed 10, Unknown 2, Recruiting 1, Terminated 1
Phase 28Completed 6, Terminated 1, Withdrawn 1
Phase 38Completed 5, Recruiting 1, Unknown 1, Withdrawn 1
Phase 13Active not recruiting 1, Completed 1, Unknown 1
Early Phase 12Not yet recruiting 1, Terminated 1

Follow Mupirocin: new trials by email Literature Review of Mupirocin trials Research Report on Mupirocin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Thermosensitive Gel Nasal Spray With Stem Cell Exosomes, Mupirocin, and DNase I for Chronic Sinusitis
Exosomes (hUC-MSC-Exo), Mupirocin, DNase I - Chronic Rhinosinusitis With Nasal Polyps
Early Phase 1Not yet recruitingThe First Affiliated Hospital of Xinxiang Medical College1082026-07-012026-06-09
Decolonization Efficacy of Polyhexanide vs. Mupirocin
Polyhexanide, Mupirocin and Chlorhexidine - Staphylococcus Aureus, Colonization, Asymptomatic
Phase 4CompletedSwiss Paraplegic Research, Nottwil242025-05-012026-07-08
Bacterial Decolonization Within Dyads
Mupirocin, Chlorhexidine baths - Bacterial Colonization
Not applicableCompletedDuke University12024-08-212026-06-03
Staph Intervention for Effective Local Defense
Mupirocin + Nozin + chlorhexidine gluconate, Education + Household supplies - Staphylococcus Aureus Infection
Phase 4CompletedJohns Hopkins Bloomberg School of Public Health782024-04-012026-06-12
Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study
Mupirocin (50 mg), Mupirocin (500 mg), blood samples after Single dose part - Healthy, Staphylococcus Aureus Infection
Phase 1Active not recruitingCentre Hospitalier Universitaire de Saint Etienne402024-02-292025-07-03
Efficacy of Hydrocolloid Dressing vs. Topical Antibiotic on Wound Healing of Post-Punch Biopsy Wounds
Mupirocin (drug), Hydrocolloid Dressing (DuoDERM CGF) - Biopsy Wound
Not applicableCompletedUniversity of Santo Tomas Hospital, Philippines602024-01-292025-08-24
Mupirocin 2% Ointment Vs Spray Antibiotics on Temporary Hemodialysis Catheter
Local antibiotic spray Neomycin sulphate 165,000 IU + Bacitracin zinc 12,500 IU, Mupirocin 2% ointment - Hemodialysis Complication, Hemodialysis Catheter Infection
Phase 2 / Phase 3CompletedFuture University in Egypt1502023-04-102023-08-22
The Effect of Bacterial Decolonization Before Skin Cancer Surgery on Infection Rate of Lower Extremity Wounds Left Open to Heal
Chlorhexidine gluconate (4%), Mupirocin 2% Ointment - Surgical Wound Infection
Phase 3RecruitingThe Cooper Health System8482023-03-132025-08-26
Decolonization to Reduce After-Surgery Events of Surgical Site Infection
4% Chlorhexidine Gluconate, 2% Mupirocin, Soap Without Antiseptic Properties (Placebo) - Surgical Site Infection
Phase 4RecruitingUniversity of California, Irvine27002023-01-172026-07-21
Effects of Topical Gentamicin on the Prevention of Peritoneal Dialysis Related Infection
Mupirocin, Gentamicin - Peritoneal Dialysis-related Infection
Not applicableUnknownPhramongkutklao College of Medicine and Hospital602021-12-012022-02-22
To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions
Mupirocin Calcium, Vehicle - Secondarily Infected Traumatic Skin Lesions
Phase 3CompletedPadagis LLC6572019-10-152022-11-03
Topical Antibiotics in Chronic Rhinosinusitis
Mupirocin, Tobramycin, Levofloxacin - Chronic Rhinosinusitis (Diagnosis)
Phase 1 / Phase 2CompletedMayo Clinic192018-09-262022-04-20
STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)
Trimethoprim Sulfamethoxazole (TMP/SMX), Minocycline, Mupirocin - Cystic Fibrosis
Phase 2CompletedUniversity of North Carolina, Chapel Hill492018-04-032026-09-15
Comparison of Topical Therapies in Post op Endoscopic Sinus Surgery Patients
Saline Nasal, Budesonide Nasal, Topical Antibacterial (Product) - Chronic Rhinosinusitis (Diagnosis)
Phase 3WithdrawnUniversity of Florida2018-04-012018-03-30
S. Aureus Decolonization in HPN Patients.
Doxycycline, Trimethoprim, Sulfamethoxazole/trimethoprim - Staphylococcus Aureus, Motility Disorder
Not applicableTerminatedRadboud University Medical Center632018-02-082022-05-31
Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
Mupirocin, Placebo - Hereditary Hemorrhagic Telangiectasia, Epistaxis
Phase 3UnknownHospital Italiano de Buenos Aires402017-06-012016-11-15
Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial
Mupirocin 2% nasal ointement, Chlorhexidine sol 4% - Orthopedic Disorders, Surgical Site Infection
Not applicableCompletedLindenhofgruppe AG13002015-11-012018-02-27
Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence
2% mupirocin ointment, Chlorhexidine wash, Hygiene protocol - Methicillin-Resistant Staphylococcus Aureus, Recurrence
Phase 4UnknownClinical Directors Network2782015-10-012017-07-21
Staph Household Intervention for Eradication (SHINE)
Chlorhexidine, Mupirocin, Household cleaning - Skin and Subcutaneous Tissue Bacterial Infections, Staphylococcus Aureus
Phase 4CompletedWashington University School of Medicine8352015-10-012026-02-24
Treating Parents to Reduce NICU Transmission of Staphylococcus Aureus Trial
Mupirocin and Chlorhexidine, Placebo ointment and placebo cloths - Staph Aureus Colonization, Staph Aureus Infection
Not applicableCompletedJohns Hopkins University3072014-11-012022-01-11

Showing 20 of 53. Sign in to see all of them.

Conditions studied

Staphylococcal Infections (20)  ·  Surgical Wound Infection (6)  ·  Abscess (5)  ·  Impetigo (4)  ·  Staphylococcal Skin Infections (4)  ·  Cellulitis (3)  ·  Cystic Fibrosis (3)  ·  Furunculosis (3)  ·  Infections (3)  ·  Disease (2)  ·  Asymptomatic Infections (1)  ·  Critical Illness (1)  ·  Cross Infection (1)  ·  Dermatitis, Atopic (1)  ·  Digestive System Diseases (1)

Sponsors

Washington University School of Medicine (4)  ·  Johns Hopkins University (3)  ·  GlaxoSmithKline (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  B. Braun Medical SA (1)  ·  Brooke Army Medical Center (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Chikara Tashiro (1)  ·  Children's Hospital of Philadelphia (1)  ·  Clinical Directors Network (1)  ·  Destiny Pharma Plc (1)  ·  Duke University (1)  ·  Endeavor Health (1)  ·  Future University in Egypt (1)

Countries

United States (32)  ·  Philippines (2)  ·  Spain (2)  ·  Switzerland (2)  ·  Argentina (1)  ·  Canada (1)  ·  Denmark (1)  ·  Egypt (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Israel (1)  ·  Japan (1)  ·  Netherlands (1)  ·  South Africa (1)

Top investigators

Stephanie A Fritz, MD, MSCI (2)  ·  Aaron Milstone, MD, MHS (1)  ·  Albert C. Yan, MD (1)  ·  Almena L Free, MD (1)  ·  Amy Paller, MD (1)  ·  Bernard C. Camins, MD, MSCR (1)  ·  Chris Goss, MD (1)  ·  Christof von Eiff, MD (1)  ·  Craig D Brown, BSc (Med), MD, FRCSC, FACS (1)  ·  Daraporn Rungprai, BCP (1)  ·  David Seligson, MD (1)  ·  Deborah Yokoe, MD, MPH (1)  ·  Doaa ElBohy, PhD (1)  ·  Eli N. Perencevich, MD MS BS (1)

Results publications

PMID 36511181, PMID 15276398, PMID 15840453, PMID 18702902, PMID 19128645, PMID 19403473, PMID 19588358, PMID 21828967, PMID 22033452, PMID 22198793, PMID 22311838, PMID 22530208, PMID 22980682, PMID 23776108, PMID 23796939, PMID 24119597, PMID 25239721, PMID 25832968, PMID 26018036, PMID 26353875, PMID 26363164, PMID 26380335, PMID 27440128, PMID 27466854, PMID 27492790, PMID 27556896, PMID 27852955, PMID 28124652, PMID 29954418, PMID 30587533, PMID 31737738, PMID 31886828, PMID 32521007, PMID 33618788, PMID 35342110, PMID 36925849, PMID 36965196, PMID 37471087, PMID 4902833, PMID 8948280

NIH funding

S06GM142120 (1)